Driving Adoption of Spatial Biology & Digital Pathology to De-Risk Clinical Decisions, Unlock Multimodal Insights & Accelerate Translational Workflows with Greater Accuracy & Scalability
As spatial biology, digital pathology, and AI rapidly intersect, biopharma is shifting its focus from platform innovation to practical, scalable deployment. With Labcorp and Roche collaborating to advance digital pathology, and Vizgen and Hamamatsu partnering to streamline spatial biology workflows, the potential of these technologies has never been greater.
The 4th AI-Enabled Spatial Biology & Digital Pathology Summit San Diego stands as the definitive meeting point for teams determined to operationalize these tools. Purpose-built for translational experts, pathologists, bioinformaticians, and diagnostic leaders, the summit unites 70+ decision-makers to share strategies that enable efficient implementation. From data infrastructure, multimodal workflow integration, multiplex imaging, and AI-driven analysis, this forum will equip you with practical pathways to de-risk pipelines, accelerate therapeutic development and fully harness the value of spatial and digital technologies.
Attending Companies Include